Literature DB >> 35809216

Inter- and intra-chromosomal modulators of the APOE ɛ2 and ɛ4 effects on the Alzheimer's disease risk.

Alireza Nazarian1, Ian Philipp2, Irina Culminskaya2, Liang He2, Alexander M Kulminski3.   

Abstract

The mechanisms of incomplete penetrance of risk-modifying impacts of apolipoprotein E (APOE) ε2 and ε4 alleles on Alzheimer's disease (AD) have not been fully understood. We performed genome-wide analysis of differences in linkage disequilibrium (LD) patterns between 6,136 AD-affected and 10,555 AD-unaffected subjects from five independent studies to explore whether the association of the APOE ε2 allele (encoded by rs7412 polymorphism) and ε4 allele (encoded by rs429358 polymorphism) with AD was modulated by autosomal polymorphisms. The LD analysis identified 24 (mostly inter-chromosomal) and 57 (primarily intra-chromosomal) autosomal polymorphisms with significant differences in LD with either rs7412 or rs429358, respectively, between AD-affected and AD-unaffected subjects, indicating their potential modulatory roles. Our Cox regression analysis showed that minor alleles of four inter-chromosomal and ten intra-chromosomal polymorphisms exerted significant modulating effects on the ε2- and ε4-associated AD risks, respectively, and identified ε2-independent (rs2884183 polymorphism, 11q22.3) and ε4-independent (rs483082 polymorphism, 19q13.32) associations with AD. Our functional analysis highlighted ε2- and/or ε4-linked processes affecting the lipid and lipoprotein metabolism and cell junction organization which may contribute to AD pathogenesis. These findings provide insights into the ε2- and ε4-associated mechanisms of AD pathogenesis, underlying their incomplete penetrance.
© 2022. The Author(s).

Entities:  

Keywords:  Aging; Compound genotype; Cox regression; Dementia; Genetic heterogeneity; LD

Year:  2022        PMID: 35809216     DOI: 10.1007/s11357-022-00617-0

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  58 in total

1.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors:  Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal:  Genomics       Date:  2007-04-16       Impact factor: 5.736

Review 2.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

Review 3.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

4.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

5.  APOE and Alzheimer disease: a major gene with semi-dominant inheritance.

Authors:  E Genin; D Hannequin; D Wallon; K Sleegers; M Hiltunen; O Combarros; M J Bullido; S Engelborghs; P De Deyn; C Berr; F Pasquier; B Dubois; G Tognoni; N Fiévet; N Brouwers; K Bettens; B Arosio; E Coto; M Del Zompo; I Mateo; J Epelbaum; A Frank-Garcia; S Helisalmi; E Porcellini; A Pilotto; P Forti; R Ferri; E Scarpini; G Siciliano; V Solfrizzi; S Sorbi; G Spalletta; F Valdivieso; S Vepsäläinen; V Alvarez; P Bosco; M Mancuso; F Panza; B Nacmias; P Bossù; O Hanon; P Piccardi; G Annoni; D Seripa; D Galimberti; F Licastro; H Soininen; J-F Dartigues; M I Kamboh; C Van Broeckhoven; J C Lambert; P Amouyel; D Campion
Journal:  Mol Psychiatry       Date:  2011-05-10       Impact factor: 15.992

6.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

7.  Tree scanning: a method for using haplotype trees in phenotype/genotype association studies.

Authors:  Alan R Templeton; Taylor Maxwell; David Posada; Jari H Stengård; Eric Boerwinkle; Charles F Sing
Journal:  Genetics       Date:  2004-09-15       Impact factor: 4.562

8.  Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.

Authors:  G Lucotte; S Visvikis; B Leininger-Müler; F David; S Berriche; S Réveilleau; R Couderc; M C Babron; D Aguillon; G Siest
Journal:  Am J Med Genet       Date:  1994-09-15

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Disease variants in genomes of 44 centenarians.

Authors:  Yun Freudenberg-Hua; Jan Freudenberg; Vladimir Vacic; Avinash Abhyankar; Anne-Katrin Emde; Danny Ben-Avraham; Nir Barzilai; Dayna Oschwald; Erika Christen; Jeremy Koppel; Blaine Greenwald; Robert B Darnell; Soren Germer; Gil Atzmon; Peter Davies
Journal:  Mol Genet Genomic Med       Date:  2014-06-15       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.